Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019
- PMID: 37646746
- PMCID: PMC10503421
- DOI: 10.1590/1984-0462/2024/42/2022161
Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019
Abstract
Objective: To evaluate quality indicators of the Neonatal Screening Referral Service of the state of Mato Grosso (NSRS-MT) from 2005 to 2019.
Methods: Cross-sectional, retrospective, exploratory, descriptive, and observational study from 2005 to 2019. The following parameters were analyzed: age of newborns at the first collection, time between sample collection and arrival at the laboratory, time between the arrival and release of results and time between requesting the second sample and arrival at the NSRS. The population coverage of the program and the incidence of each clinical situation screened were also analyzed.
Results: NSRS-MT coverage was analyzed and recorded as 76%. The incidence was analyzed for congenital hypothyroidism (CH) 1:1867, phenylketonuria (PKU) 1:33,311, sickle cell disease (SCD) 1:2004, cystic fibrosis (CF) 1:12,663, congenital adrenal hyperplasia (CAH) 1:15,843, and biotinidase deficiency (DB) 1:25,349. The median age (days) at the first consultation was: 44 for HC, 22 for PKU, 60 for DF, 52 for FC, 79 for HAC and 79 for DB. The mean time between exam collection and delivery to the NSRS was 8.4 days; between the arrival and release of results, 9 days; and for the return of recalls, 59 days.
Conclusions: Regarding the coverage of the target population and collection at the ideal age, the NSRS-MT presents values below the national average. However, regarding the mean age at the time of the first consultation, the state's performance is better than the national.
Objetivo:: Avaliar indicadores de qualidade do Serviço de Referência em Triagem Neonatal do Estado de Mato Grosso (SRTN/MT) no período de 2005 a 2019.
Métodos:: Estudo transversal, retrospectivo, exploratório, descritivo e observacional, que utilizou dados do formulário FormSUS nos anos de 2005 a 2019. Foram analisados os seguintes parâmetros: idade dos recém-nascidos na primeira coleta, tempo entre coleta da amostra e chegada ao laboratório, tempo entre a chegada e a liberação dos resultados e tempo entre a solicitação da segunda amostra até a chegada ao SRTN. Foram analisadas, também, a cobertura populacional do programa e a incidência de cada situação clínica triada.
Resultados:: Cobertura do SRTN-MT: 76%. Incidências: hipotireoidismo congênito (HC) 1:1.867, fenilcetonúria (PKU) 1:33.311, doença falciforme (DF) 1:2.004, fibrose cística (FC) 1:12.663, hiperplasia adrenal congênita (HAC) 1:15.843 e deficiência de biotinidase (DB) 1:25.349. A mediana da idade (dias) na primeira consulta foi: 44 para HC, 22 para PKU, 60 para DF, 52 para FC, 79 para HAC e 79 para DB. A média entre a coleta do exame e a entrega no SRTN foi de 8,4 dias; entre a chegada e liberação dos resultados, de 9 dias; e para o retorno de reconvocados, de 59 dias.
Conclusões:: Com relação à cobertura da população alvo e a coleta na idade ideal, o SRTN apresenta valores abaixo da média nacional. Contudo, quanto à idade média no momento da primeira consulta, o desempenho de MT é melhor que a média nacional.
Conflict of interest statement
The authors declare there is no conflict of interests.
Figures
Similar articles
-
[Evaluation of the Neonatal Screening Program for congenital hypothyroidism and phenylketonuria in the State of Mato Grosso, Brazil].Arq Bras Endocrinol Metabol. 2009 Jun;53(4):446-52. doi: 10.1590/s0004-27302009000400010. Arq Bras Endocrinol Metabol. 2009. PMID: 19649383 Portuguese.
-
Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.J Perinat Med. 2005;33(3):246-51. doi: 10.1515/JPM.2005.045. J Perinat Med. 2005. PMID: 15914349
-
[Evolution of the neonatal screening program in the state of Tocantins].Arq Bras Endocrinol Metabol. 2013 Mar;57(2):112-9. doi: 10.1590/s0004-27302013000200003. Arq Bras Endocrinol Metabol. 2013. PMID: 23525288 Portuguese.
-
Neonatal biochemical screening for disease.Clin Chim Acta. 2002 Jan;315(1-2):99-110. doi: 10.1016/s0009-8981(01)00716-1. Clin Chim Acta. 2002. PMID: 11728413 Review.
-
Screening for metabolic disorders. How are we doing?Pediatr Clin North Am. 1993 Oct;40(5):1073-85. doi: 10.1016/s0031-3955(16)38624-2. Pediatr Clin North Am. 1993. PMID: 8414711 Review.
Cited by
-
Delays in Newborn Screening for Phenylketonuria from Birth to Diagnosis and Factors Affecting This.Children (Basel). 2024 May 9;11(5):571. doi: 10.3390/children11050571. Children (Basel). 2024. PMID: 38790566 Free PMC article.
-
A comprehensive integrated disease management program for phenylketonuria (IDMP-PKU) from Türkiye: rationale, design and patient characteristics.Orphanet J Rare Dis. 2025 Aug 1;20(1):394. doi: 10.1186/s13023-025-03702-7. Orphanet J Rare Dis. 2025. PMID: 40751258 Free PMC article.
-
Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.Int J Mol Sci. 2024 Jun 14;25(12):6578. doi: 10.3390/ijms25126578. Int J Mol Sci. 2024. PMID: 38928282 Free PMC article. Review.
References
-
- Brazil. Ministério da Saúde . Gabinete do Ministro [homepage on the Internet]. Portaria no 822, de 06 de junho de 2001. Brasília: Ministério da Saúde; 2001. [[cited 2022, jul 03]]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2001/prt0822_06_06_2001.html .
-
- Kopacek C, Castro SM, Chapper M, Amorim LB, Lüdtke C, Vargas P. Evolução e funcionamento do Programa Nacional de Triagem Neonatal no Rio Grande do Sul de 2001 a 2015. Boletim Científico de Pediatria. 2015;4(3):70–74.
-
- Brazil. Ministério da Saúde . Secretaria de Assistência à Saúde [homepage on the Internet]. Portaria no 684, de 1o de outubro de 2002. Brasilia: Diário Oficial da União; 2002. [[cited 2022, jun 02]]. Available from: https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pag... .
-
- Therrell BL, Jr, Lloyd-Puryear MA, Ohene-Frempong K, Ware RE, Padilla CD, Ambrose EE, et al. Empowering newborn screening programs in African countries through establishment of an international collaborative effort. J Community Genet. 2020;11:253–268. doi: 10.1007/s12687-020-00463-7. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous